Abstract

MCFD2 and ERGIC-53, which are the products of causative genes of combined factor V and factor VIII deficiency, form a cargo receptor complex responsible for intracellular transport of these coagulation factors in the early secretory pathway. In this study, using an NMR technique, we successfully identified an MCFD2-binding segment from factor VIII composed of a 10 amino acid sequence that enhances its secretion. This prompted us to examine possible effects of attaching this sequence to recombinant glycoproteins on their secretion. We found that the secretion level of recombinant erythropoietin was significantly increased simply by tagging it with the passport sequence. Our findings not only provide molecular basis for the intracellular trafficking of coagulation factors and their genetic deficiency but also offer a potentially useful tool for increasing the production yields of recombinant glycoproteins of biopharmaceutical interest.

The secretion of blood coagulation factor V and factor VIII (FV and FVIII) are driven by secretion factors ERGIC-53 and MCDF2. Here, the authors report a 10 amino acid motif from FVIII that can enhance secretion of another glycoprotein erythropoietin (EPO).

Details

Title
Improved secretion of glycoproteins using an N-glycan-restricted passport sequence tag recognized by cargo receptor
Author
Yagi Hirokazu 1   VIAFID ORCID Logo  ; Yagi-Utsumi Maho 2   VIAFID ORCID Logo  ; Honda Rena 3 ; Ohta Yusaku 4 ; Saito Taiki 1 ; Nishio Miho 1 ; Ninagawa Satoshi 5   VIAFID ORCID Logo  ; Suzuki, Kousuke 1 ; Anzai Takahiro 5   VIAFID ORCID Logo  ; Kamiya Yukiko 5   VIAFID ORCID Logo  ; Aoki Kazuhiro 4   VIAFID ORCID Logo  ; Nakanishi Mahito 6 ; Satoh Tadashi 1   VIAFID ORCID Logo  ; Kato Koichi 2   VIAFID ORCID Logo 

 Nagoya City University, Graduate School of Pharmaceutical Sciences, Nagoya, Japan (GRID:grid.260433.0) (ISNI:0000 0001 0728 1069) 
 Nagoya City University, Graduate School of Pharmaceutical Sciences, Nagoya, Japan (GRID:grid.260433.0) (ISNI:0000 0001 0728 1069); National Institutes of Natural Sciences, Exploratory Research Center on Life and Living Systems (ExCELLS), Okazaki, Japan (GRID:grid.250358.9) (ISNI:0000 0000 9137 6732); National Institutes of Natural Sciences, Institute for Molecular Science, Okazaki, Japan (GRID:grid.250358.9) (ISNI:0000 0000 9137 6732); SOKENDAI (The Graduate University for Advanced Studies), School of Physical Science, Okazaki, Japan (GRID:grid.275033.0) (ISNI:0000 0004 1763 208X) 
 Nagoya City University, Graduate School of Pharmaceutical Sciences, Nagoya, Japan (GRID:grid.260433.0) (ISNI:0000 0001 0728 1069); National Institutes of Natural Sciences, Institute for Molecular Science, Okazaki, Japan (GRID:grid.250358.9) (ISNI:0000 0000 9137 6732); SOKENDAI (The Graduate University for Advanced Studies), School of Physical Science, Okazaki, Japan (GRID:grid.275033.0) (ISNI:0000 0004 1763 208X) 
 National Institutes of Natural Sciences, Exploratory Research Center on Life and Living Systems (ExCELLS), Okazaki, Japan (GRID:grid.250358.9) (ISNI:0000 0000 9137 6732); National Institutes of Natural Sciences, National Institute for Basic Biology, Okazaki, Japan (GRID:grid.250358.9) (ISNI:0000 0000 9137 6732) 
 National Institutes of Natural Sciences, Institute for Molecular Science, Okazaki, Japan (GRID:grid.250358.9) (ISNI:0000 0000 9137 6732) 
 National Institute of Advanced Industrial Science and Technology (AIST), Biotechnology Research Institute for Drug Discovery, Ibaraki, Japan (GRID:grid.208504.b) (ISNI:0000 0001 2230 7538) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2376946477
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.